Headlands Research

Headlands Research (operating at headlandsresearch.com) is a multinational, integrated clinical trial site organization engineered for accelerating the development of innovative medical therapies. Founded in 2018 and headquartered in San Francisco, California, Headlands Research specializes in streamlining clinical research operations—a domain traditionally plagued by fragmented site management, regulatory complexity, and inefficiencies. Unlike traditional contract research organizations (CROs) that often operate in silos, Headlands Research consolidates trial execution across multiple therapeutic areas, including Endocrine and Metabolic Disorders, Pain, Respiratory, and general medicine, with a proven track record in high-impact studies like COVID-19 trials. Under the hood, the company leverages a globally integrated network of clinical sites, ensuring standardized protocols, real-time data management, and seamless collaboration between sponsors, investigators, and patients. This allows pharmaceutical companies and biotech firms to accelerate trial timelines, reduce operational costs, and improve patient recruitment and retention. While specific funding details remain proprietary, the company’s acquisition by THL in 2021 underscores its strategic value in the clinical research ecosystem.